Insider Transactions in Q1 2022 at Kymera Therapeutics, Inc. (KYMR)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2022
|
Elaine Caughey Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+50.0%
|
-
|
|
Mar 01
2022
|
Jared Gollob Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,600
+25.27%
|
-
|
|
Mar 01
2022
|
Bruce N. Jacobs Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,300
+24.58%
|
-
|
|
Jan 31
2022
|
Bvf Partners L P Director |
BUY
Open market or private purchase
|
Direct |
34,408
+1.03%
|
$1,376,320
$40.7 P/Share
|
|
Jan 27
2022
|
Bvf Partners L P Director |
BUY
Open market or private purchase
|
Direct |
95,901
+2.83%
|
$3,644,238
$38.33 P/Share
|
|
Jan 24
2022
|
Bvf Partners L P Director |
BUY
Open market or private purchase
|
Direct |
272,767
+7.92%
|
$10,092,379
$37.76 P/Share
|
|
Jan 14
2022
|
Bruce N. Jacobs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+26.66%
|
$20,000
$2.08 P/Share
|
|
Jan 14
2022
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.03%
|
$20,000
$2.08 P/Share
|
|
Jan 12
2022
|
Bruce N. Jacobs Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-18.23%
|
$780,000
$52.2 P/Share
|
|
Jan 12
2022
|
Bruce N. Jacobs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+31.57%
|
$30,000
$2.08 P/Share
|
|
Jan 12
2022
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,612
-0.45%
|
$447,824
$52.64 P/Share
|
|
Jan 12
2022
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,612
+1.76%
|
$17,224
$2.08 P/Share
|
|
Jan 11
2022
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,923
-1.16%
|
$913,842
$54.38 P/Share
|
|
Jan 11
2022
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,923
+3.34%
|
$33,846
$2.08 P/Share
|
|
Jan 10
2022
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
22,465
-1.15%
|
$1,190,645
$53.8 P/Share
|
|
Jan 10
2022
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,465
+4.34%
|
$44,930
$2.08 P/Share
|